HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tat-conjugated synthetic macromolecules facilitate cytoplasmic drug delivery to human ovarian carcinoma cells.

Abstract
We have synthesized N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer-cell penetrating peptide Tat conjugates and evaluated their subcellular distribution in A2780 human ovarian carcinoma cells by confocal fluorescence microscopy and subcellular fractionation. Our data indicate the transport of these conjugates by a single Tat molecule to both the cytoplasm and nucleus via a nonendocytotic and concentration independent process. The uptake was observed to occur within 3 min, as confirmed by live cell microscopy. In contrast, HPMA copolymers lacking the Tat peptide were internalized solely by endocytosis. For the first time, Tat-mediated cytoplasmic delivery of a polymer bound anticancer drug, doxorubicin, was also demonstrated. These findings establish the feasibility of overcoming major cellular and subcellular obstacles to intracellular macromolecular delivery and hold great promise for the development of polymer-based systems for the cytoplasmic delivery of therapeutic molecules.
AuthorsAparna Nori, Keith D Jensen, Monica Tijerina, Pavla Kopecková, Jindrich Kopecek
JournalBioconjugate chemistry (Bioconjug Chem) 2003 Jan-Feb Vol. 14 Issue 1 Pg. 44-50 ISSN: 1043-1802 [Print] United States
PMID12526691 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Drug Carriers
  • Gene Products, tat
  • Methacrylates
  • Polymers
  • hydroxypropyl methacrylate
Topics
  • Cell Nucleus (metabolism)
  • Cytoplasm (metabolism)
  • Drug Carriers (chemistry, pharmacokinetics)
  • Female
  • Gene Products, tat (chemistry, pharmacokinetics)
  • Humans
  • Methacrylates
  • Microscopy, Fluorescence
  • Ovarian Neoplasms (pathology)
  • Polymers (chemistry, pharmacokinetics)
  • Transport Vesicles (metabolism)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: